Schnurri (Shn)-2 is a large zinc finger-containing protein, which plays a critical role in cell growth, signal transduction and lymphocyte development. In Shn-2-deficient (Shn-2 2/2 ) CD4 T cells, the activation of nuclear factor-kB is up-regulated and their ability to differentiate into T h 2 is enhanced. Here, we extend our investigation and demonstrate that Shn-2 regulates T h 2 responses in vivo using an ovalbumin-induced allergic asthma model. Eosinophilic inflammation, mucus hyperproduction and airway hyperresponsiveness (AHR) were all enhanced in Shn-2 2/2 mice. Moreover, eosinophilic infiltration and AHR were enhanced in mice given a transfer of Shn-2 2/2 effector T h 2. Shn-2 in T h 2 is thus considered to play an important role as a negative regulator in allergic airway inflammation.
Introduction
Drosophila Schnurri (Shn) is a large zinc-finger containing protein with a molecular weight of ;270 kDa. Drosophila Mad-Medea and Shn interact with each other and act as nuclear targets in the Drosophila decapentaplegic-signaling pathway (1) (2) (3) . In vertebrates, this signaling pathway may equate to the bone morphogenetic protein/transforming growth factor-b/activin-signaling pathways which play diverse roles in the developmental processes. Vertebrates have at least three orthologs of Shn, namely Shn-1, Shn-2 and Shn-3 (4) . mRNA expression of Shn-2 was detected primarily in the brain, heart and spleen. The vertebrate homologs of Shn were originally identified as proteins that bind to the nuclear factor-jB (NF-jB) site of various genes (5) . Recently, the role of Shn-2 in the positive selection of thymocytes has been reported (6) , and Shn-3-deficient CD4 +
CD8
+ thymocytes were shown to exhibit a defect in cell survival (7) . We recently demonstrated that Shn-2 binds to the NF-jB motif directly, thus resulting in the repression of the transcriptional activity of NF-jB through the competition of NF-jB binding in T cells (8). Shn-2-deficient (Shn-2 À/À ) CD4 T cells showed an increased capability to differentiate into T h 2, due to the constitutive activation of NF-jB and the subsequent up-regulation of GATA3 expression (8). However, the precise physiological roles of these Shn family member proteins in in vivo immune responses still remain largely unknown.
T h 2 play an important role in allergic asthma by inducing allergen-specific IgE production, airway inflammation, airway hyperresponsiveness (AHR) and mucus hyperproduction (9) (10) (11) (12) (13) . The administration of allergens adsorbed with alum induces reproducible allergen-specific acquired immune responses that are dependent on T h 2 producing IL-4, IL-5 and IL-13. A subsequent allergen challenge via the airway causes the rapid activation of T h 2, mast cells and B cells. This activation results in increased vascular permeability, cellular infiltration into the lung tissue, smooth muscle contraction and mucus secretion.
In this study, we investigated the role of Shn-2 in allergic inflammation using Shn-2 À/À mice. Our results suggest that Shn-2 plays a crucial role in the regulation of allergic airway inflammation and AHR.
Methods

Mice
Shn-2
À/À mice have been described previously (6, 8) . The animals used in this study were backcrossed to BALB/c >12 times and were 7-9 weeks old. Anti-ovalbumin (OVA)-specific TCRab (DO11.10) transgenic (Tg) mice were provided by Dennis Loh (Washington University School of Medicine, St Louis, MO, USA) (14) . BALB/c mice were purchased from Clea Inc., Tokyo, Japan. Mice used in this study were at 7-9 weeks of age. Three independent experiments were performed for each experiment. All mice used in this study were maintained under specific pathogen-free conditions. All animal care was conducted in accordance with the guidelines of Chiba University.
Sensitization and airway challenge with OVA The mice were sensitized by an intra-peritoneal injection of 100 lg OVA (Sigma-Aldrich, St Louis, MO, USA) adsorbed to 1 mg alum (LSL, Tokyo, Japan) on day 0. OVA solution in PBS (100 lg per 30 ll) was administered intra-nasally to each mouse on days 7 and 9.
Measurement of AHR
The degree of AHR was assessed by methacholine-induced airflow obstruction 24 h after the last antigen challenge. The respiratory parameters were obtained by exposure of mice to 0.9% saline mist, followed by incremental doses of aerosolized methacholine (0, 3, 6, 12, 24 and 48 mg ml À1 in saline). Airflow obstruction was monitored and analyzed by whole-body plethysmograph (Buxco Electronics, Wilmington, NC, USA) as described previously (15) . The results are expressed as the average in percentages of baseline enhanced paused values. The degree of AHR was also assessed by a computer-controlled small animal ventilator (SCIREQ, Montreal, Canada) (16) . In brief, the mice were anesthetized with 100 ll per 10 g body weight of 50 mg ml À1 pentobarbital sodium given intra-peritoneally. After performing a tracheotomy, the trachea was cannulated with a blunted 18-gage needle. These mice were ventilated with a tidal volume of 10 ml kg À1 at a frequency of 180 breath min À1 . Each mouse was challenged with increasing doses of methacholine aerosol. After each challenge, lung resistance (RL) was recorded during tidal breathing every 10 s.
The maximum values of RL were determined and expressed as the percent changes from baseline after saline exposure.
Collection of bronchioalveolar lavage fluid
Bronchioalveolar lavage (BAL) was performed 48 h after the last OVA challenge as described previously (17) . All BAL fluid was collected and the cells were counted in 100-ll aliquots. One hundred thousand viable BAL cells were cytocentrifuged onto slides by a Cytospin 4 (Thermo Electron, Waltham, MA, USA) and stained with May-Grunwald-Giemza solution (MERCK, Darmstadt, Germany). Two hundred leukocytes were counted on each slide. Cell types were identified using morphological criteria. The percentages of each cell type were calculated. Cytokine levels in the BAL fluid were measured 6 h after the last OVA challenges. IL-5, IL-13 and eotaxin-2 levels in BAL fluid were measured by ELISA as previously described (18) .
Lung histology
The mice were sacrificed by asphyxiation at 48 h after the last OVA challenge, and the lungs were infused with 10% (v/v) formalin in PBS for fixation. The lung samples were sectioned, stained with hematoxylin and eosin (H&E) reagents or periodic acid-Schiff (PAS) reagent and examined for pathological changes under a light microscope at 3200. The number of infiltrated mononuclear cells in the peribronchiolar regions was calculated by direct counting in four different fields per slide.
Lung mononuclear cell preparation and a flow cytometry analysis
The lungs were sliced into small cubes and then incubated for 30 min in 5 ml RPMI 1640 solution containing collagenase (20 U ml À1 ) (Worthington, Lakewood, NJ, USA) and trypsin inhibitor (0.3 mg ml À1 ) (Sigma-Aldrich). Lung mononuclear cells were separated by centrifugation on Percoll (GE Healthcare, Buckinghamshire, UK). For staining, one million cells were incubated on ice for 30 min with the appropriate staining reagents, according to a standard method (19) . The reagents used in this study were antiCD8a-PE (53-6.7) and anti-CD4-APC[K2] (RM4-5) purchased from PharMingen (San Diego, CA, USA). A flow cytometry analysis was performed on FACScalibur TM [K3] (Becton Dickinson, Franklin lakes, NJ, USA) and the results were analyzed using the CELLQUEST TM software program (Becton Dickinson).
Adoptive cell transfer of T h 2 for the development of airway inflammation and AHR
Effector T h 2 were generated as previously described (20) . In brief, splenic CD4 T cells purified from DO11.10 OVAspecific TCR Tg or Shn-2 À/À DO11.10 OVA-specific TCR Tg mice were stimulated with an OVA peptide (Loh15, 3 lM) plus antigen presenting cells under T h 2 culture conditions for 6 days in vitro. These effector T h 2 (5 3 10 À6 ) were transferred intravenously into BALB/c recipient mice on day 0. These recipient mice were not irradiated. On day 1 and 3, OVA solution (100 lg per 30 ll) was administrated intranasally to each mouse. The degree of AHR was measured on day 4. BAL fluid was collected on day 5.
Quantitative PCR analysis
Total RNA was isolated from the lung (three mice in each group) using the TRIzol reagent (Sigma-Aldrich). Reverse transcription (RT) was carried out with Superscript II RT (Invitrogen, Carlsbad, CA, USA). Samples were then subjected to real-time PCR analysis on an ABI PRISM 7300 Sequence Detection System (Applied Biosystems, Foster City, CA, USA) under standard conditions. The primers and TaqMan probes for the detection of Muc5ac, thymus activationregulated chemokine (TARC), macrophage-derived chemokine (MDC) and hypoxanthine-guanine phosphoribosyltransferase (hprt) were purchased from Applied Biosystems. The expression of mRNA was normalized using the hprt signal.
Data analysis
The statistical analysis was performed using the two-tailed Student's t-test. Mann-Whitney U-tests were used to determine the level of difference in the degree of AHR. The values are the mean 6 SD.
Results
Enhanced eosinophilic infiltration in BAL fluid and AHR in Shn-2 À/À mice
We recently reported that the ability to differentiate into T h 2 in vitro was enhanced in Shn-2 À/À naive CD4 T cells (8). The aim of this study was to clarify the role of Shn-2 in T h 2-dependent in vivo immune responses, such as OVA-induced allergic airway inflammation. Wild-type and Shn-2 À/À mice were immunized with OVA-alum on day 0 and challenged with OVA intra-nasally on day 7 and 9. On day 11, BAL fluid was harvested and examined. The absolute numbers of eosinophils, lymphocytes, neutrophils and macrophages were determined by cell counts based on morphological criteria. As shown in Fig. 1(A) , total cell numbers of infiltrating leukocyte significantly increased in the Shn-2 À/À allergyinduced mice. A significant increase in the absolute number of eosinophils was also observed. In Shn-2 À/À mice, both OVA immunization and OVA challenge were required for the induction of allergic inflammation. The levels of IL-5, IL-13 and eotaxin-2 were increased in allergy-induced Shn-2 À/À mice in comparison to the levels in wild-type mice (Fig. 1B) . No IL-4 was detected in the BAL fluid (data not shown).
We examined the degree of AHR in the allergy-induced Shn-2 À/À mice by measuring methacholine-induced airflow obstruction with a whole-body plethysmograph (Fig. 1C) and a mechanical ventilator (Fig. 1D) . The degree of AHR in Shn-2 À/À mice was enhanced in comparison to that of wild-type mice. These data indicate that OVA-induced airway inflammation and AHR are therefore enhanced in allergy-induced Shn-2 À/À mice.
Enhanced lung inflammation and mucus production in the lung of Shn-2 À/À mice
We examined the histological changes in the lungs of allergy-induced Shn-2 À/À mice by H&E staining ( Fig. 2A , left panels). No massive inflammatory cell infiltration was noted in the lungs of wild-type and Shn-2 À/À mice that did not receive the OVA challenge ( Fig. 2A, panels a and c) . Substantial numbers of mononuclear cells were infiltrated in the peribronchiolar regions in wild-type mice after the OVA challenge ( Fig. 2A, panel b) , and the infiltration extended to the surrounding area in Shn-2 À/À mice ( Fig. 2A, panel d) . The number of infiltrated cells also increased in Shn-2 À/À mice ( Fig. 2A, right panels) .
We then examined the levels of mucus hyperproduction by PAS staining. Representative staining profiles of the bronchiolar regions in allergy-induced Shn-2 À/À mice are shown (Fig. 2B) . No specific staining was detected in wild-type and Shn-2 À/À mice without the OVA challenge (Fig. 2B , panels a and c). Moderate staining was noted in wild-type bronchioles, whereas the staining levels increased in the Four independent experiments were done with similar results. The differences were statistically significant between wild-type and Shn-2 À/À mice with OVA sensitization and OVA challenge (*P < 0.05 and **P < 0.01).
Shn-2
À/À bronchioles (Fig. 2B, panels b and d) . Consequently, we examined the expression of Muc5ac in the lungs of Shn-2 À/À mice, and a slight, but significant increase in the expression was noted in the Shn-2 À/À mouse lungs (Fig.  2C) . These results indicate that the levels of mucus hyperproduction were moderately enhanced in the lungs of the allergy-induced Shn-2 À/À mice in comparison to those of the wild-type mice.
The increased number of lung CD4 T cells in Shn-2 À/À mice is accompanied with an enhanced production of TARC and MDC Previous studies have reported a reduced number of CD4 T cells in the spleen of Shn-2 À/À mice (8). We therefore examined whether the number of CD4 T cells were reduced in OVA-sensitized Shn-2 À/À mice. Lung leukocytes were stained with anti-CD4 and anti-CD8 mAbs and analyzed by flow cytometry. The percentages of CD4 + and CD8 + cells in Shn-2 À/À mice significantly decreased in comparison to those in wild-type mice (Fig. 3A) . After the OVA challenge, the percentage of CD4 T cells increased substantially in the Shn-2 À/À mice (12.1 versus 23.4%). The absolute numbers of total leukocytes and CD4 T cells in the lung decreased significantly in Shn-2 À/À mice (Fig. 3B, upper panels) . However, a dramatic increase in the total numbers of lung leukocytes and CD4 T cells was observed in the Shn-2 À/À mice after the OVA challenge (Fig. 3B, lower panels) .
In our previous study, the proliferative ability of CD4 T cells in the Shn-2 À/À mice was comparable to that in the wild-type mice (8). To investigate the reason why the CD4 T cell levels increased in the allergy-induced Shn-2 À/À mice, we examined the mRNA expression of TARC and MDC. These chemokines are known to be selective attractants for T h 2 migration (21). As shown in Fig. 3(C) , the mRNA expression levels of TARC and MDC in the lung from the Shn-2 À/À mice were significantly higher than those in the wild-type mice. The increased expression of TARC and MDC may thus explain the dramatic increase observed in the number of CD4 T cells in the lungs of Shn-2 À/À mice.
Shn-2 À/À effector T h 2 enhanced AHR and eosinophilic infiltration into the lungs in recipient mice
We performed adoptive transfer experiments to determine whether the enhancement of airway inflammation and AHR observed in Shn-2 À/À mice is mediated via Shn-2 À/À T h 2. Effector T h 2 from Shn-2 À/À DO11.10 OVA-specific TCR Tg mice were prepared as described in the Methods. On days 1 and 3 after effector T h 2 transfer into syngeneic BALB/c mice, airway inflammation was induced by the OVA intranasal administration. A significant increase in the absolute number of eosinophilic infiltration in BAL fluid was observed in the mice that received Shn-2 À/À T h 2 (Fig. 4A) . The levels of IL-5 and eotaxin-2 in the BAL fluid from the mice receiving Shn-2 À/À T h 2 increased markedly more than that from the mice receiving wild-type T h 2 (Fig. 4B) . The levels of IL-4 were not increased but moderately decreased. The levels of IL-13 were comparable. The degree of AHR in the mice receiving Shn-2 À/À T h 2 also increased more than that in the mice receiving wild-type T h 2 ( Fig. 4C and D) . These results suggest that the hyperactivation of effector T h 2 in Shn-2 À/À mice exacerbates the development of allergic airway inflammation.
We then examined the levels of mucus hyperproduction by PAS staining. Representative staining profiles of the bronchiolar regions in the mice that received wild-type or Shn-2 À/À T h 2 are shown (Fig. 4E) . Moderate staining was noted in both bronchioles (Fig. 4E, panels a and b) . The mRNA expression of Muc5ac in the lung of mice that received Shn-2 À/À T h 2 was examined, and it was found to be comparable to that in the mice receiving wild-type T h 2 (Fig. 4F) . These results indicate that the levels of mucus hyperproduction in the lungs of the mice that received Shn-2 À/À T h 2 are therefore comparable to those of the mice that received wild-type T h 2.
Discussion
We previously reported that the activation of NF-jB to be up-regulated in Shn-2 À/À CD4 T cells, and their ability to differentiate into T h 2 was enhanced (8). In this study, we demonstrated that OVA-induced allergic inflammation and AHR are enhanced in the Shn-2 À/À mice as well as in the wild-type mice transferred with Shn-2 À/À effector T h 2. These results indicate that Shn-2 regulates OVA-induced airway inflammation and AHR through the control of CD4 T cell activation.
We observed an increased IL-5, IL-13 and eotaxin-2 level in the BAL fluid in OVA-sensitized and OVA-challenged Shn-2 À/À mice (Fig. 1B) . IL-13 is known to induce AHR in the absence of inflammatory cells (13) . IL-5 and eotaxin-2 are known to attract eosinophils (22) . Since eosinophils release granule proteins that are cytotoxic to the airway epithelium such as major basic proteins, eosinophilia may exacerbate the airway obstruction and AHR (23) . Therefore, it is likely that the overproduction of these factors (IL-5, IL-13 and eotaxin-2) resulted in the enhanced eosinophilic infiltration and AHR in the airways of the Shn-2 À/À mice. The hyperproduction of mucus also plays an important role in the pathogenesis of various asthmatic features and is linked with À/À mice without OVA challenge ( ## P < 0.01). The differences in the number of CD4 T cells were statistically significant between the wild-type mice and the Shn-2 À/À mice with OVA sensitization and OVA challenge (**P < 0.01). (C) Total mRNA was prepared from the lung of allergy-induced wild-type or Shn-2 À/À mice. A real-time RT-PCR analysis for TARC and MDC as well as hprt (as a control) was performed. Representative data of three individual animals from three independent experiments are shown (*P < 0.05).
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asthma fatality (24, 25) . IL-13 has been shown to induce mucus hypersecretion in vivo and in vitro (26) . Therefore, an overproduction of IL-13 may induce severe mucus secretion in the Shn-2 À/À lung. IL-13 was also shown to induce TARC and MDC production from keratinocytes and bronchial epithelial cells (27, 28) . The increased number of CD4 T cells in the lungs of the Shn-2 À/À mice may be due to the increased amount of IL-13, which thus resulted in the overproduction of TARC and MDC.
To investigate whether the exacerbation of airway inflammation and AHR was due to the deficiency of Shn-2 in T h 2, we performed a set of experiments with adoptive transfer of T h 2 (Fig. 4) . As a result, an enhanced degree of eosinophilic infiltration and increased levels of IL-5 and eotaxin-2 in BAL fluid were observed in wild-type recipient mice transferred with Shn-2 À/À T h 2. The degree of AHR was also amplified. Therefore, the exacerbation of airway inflammation and AHR appears to be at least in part due to the enhanced T h 2 activities of Shn-2 À/À T h 2. However, the levels of IL-13 in the BAL fluid from the mice that received Shn-2 À/À T h 2 were comparable to those from the mice that received wild-type T h 2. The levels of mucus hypersecretion did not increase in the mice that received Shn-2 À/À T h 2 ( Fig. 4E and F) . These results may indicate that the overproduction of IL-13 in the BAL fluid of Shn-2 À/À mice was not only from CD4 T cells but also from other IL-13-producing cells such as mast cells, basophils and eosinophils. We observed the Shn-2 expression in naive CD4 T cells as well as bone marrow-derived mast cells (BMMCs) (Supplementary Figure 1A , available at International Immunology Online). The phenotypic features (expression profiles of c-kit and FceRI) were indistinguishable between wild-type and Shn-2 À/À BMMCs (Supplementary Figure 1B , available at International Immunology Online.). In addition, the levels of IL-5, IL-6 and IL-13 production after cross-linking of FceRI using anti-DNP IgE and DNP-BSA were comparable (Supplementary Figure 1C , available at International Immunology Online.). The IL-4 production was not detected by ELISA in either group (C. Iwamura and T. Nakayama, unpublished observation). These results indicate that the function of Shn-2 À/À mast cells is thus within the normal range.
We observed that the production of T h 2-dependent antibodies (IgG1 and IgE) induced by OVA-alum immunization was decreased in Shn-2 À/À mice as compared with that seen in wild-type mice (M. Y. Kimura and T. Nakayama, unpublished observation). The level of IL-4 in the BAL fluid in the mice that received Shn-2 À/À T h 2 decreased (Fig. 4B ). This could be the reason why the IgG1 and IgE levels are decreased in the Shn-2 À/À mice. It is unclear at this time why the production of IL-4 in the BAL fluid of mice that received Shn-2 À/À T h 2 decreased. One possible explanation is the fact that GATA3 may play a more important role in the regulation of IL-5 production than IL-4.
In addition to T h 2, other lymphocytes substantially regulate allergic diseases. It has been reported that CD8 T cells and NKT cells are the source of IL-13 and can induce the airway inflammation and AHR independently from conventional CD4 T cells (29) (30) (31) . Regulatory T cells are also known to control allergic diseases (12, 32) . In Shn-2 À/À mice, the absolute number of CD4 + CD25 + T cells decreased in comparison to that of wild-type mice (C. Iwamura and T. Nakayama, unpublished observation). Furthermore, some Shn-2 À/À mice after 16 weeks of age died from severe whole-body inflammation of an enlarged spleen and draining lymph nodes (C. Iwamura and T. Nakayama, unpublished observation). Therefore the down-regulation of regulatory T cells may exacerbate the airway inflammation in Shn-2 À/À mice. Not only for T cells but also for non-T cell populations, such as airway smooth muscle cells, eosinophils and epithelial cells, which have all been reported to play important roles in the development of asthma (9, 22, 33) . Although we need to await a more comprehensive study, it is possible that some of these cells may express Shn-2, and thereby contribute to the exacerbation of airway inflammation and AHR in Shn-2
Recently, the role of NF-jB in the pathogenesis of allergic diseases was investigated in experimental allergic murine models (34) (35) (36) . Since Shn-2 À/À CD4 T cells showed the constitutive activation of NF-jB (8), we used an adoptive transfer system to examine whether or not the effector T h 2 with an increased activation level of NF-jB exacerbate airway inflammation and AHR. Our preliminary results showed significant increases in the absolute number of eosinophils and the degree of AHR was observed in the mice that received T h 2 over-expressing NF-jB (p65) (C. Iwamura and T. Nakayama, unpublished observation). These data suggest that the increased levels of NF-jB activation in Shn-2 À/À T h 2 may thus enhance both airway inflammation and AHR.
In summary, OVA-induced eosinophilic airway inflammation, AHR and mucus hyperproduction were all found to be enhanced in Shn-2 À/À mice. Therefore, Shn-2 appears to play a key role as an in vivo negative regulator of the T h 2-dependent allergic airway responses.
Supplementary data
Supplementary Figure 1 is available at International Immunology Online.
